» Articles » PMID: 27404554

Generation of Immature, Mature and Tolerogenic Dendritic Cells with Differing Metabolic Phenotypes

Overview
Journal J Vis Exp
Date 2016 Jul 13
PMID 27404554
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

Immune response results from a complex interplay between the antigen non-specific innate immune system and the antigen specific adaptive immune system. The immune system is a constant balance in maintaining tolerance to self-molecules and reacting rapidly to pathogens. Dendritic cells (DCs) are powerful professional antigen presenting cells that link the innate immune system to the adaptive immune system and balance the adaptive response between self and non-self. Depending on the maturation signals, immature dendritic cells can be selectively stimulated to differentiate into immunogenic or tolerogenic DCs. Immunogenic dendritic cells provide proliferation signals to antigen-specific T cells for clonal expansion; while tolerogenic dendritic cells regulate tolerance by antigen-specific T-cell deletion or clonal expansion of regulatory T-cells. Due to this unique property, dendritic cells are highly sought after as therapeutic agents for cancer and autoimmune diseases. Dendritic cells can be loaded with specific antigens in vitro and injected into the human body to mount a specific immune response both immunogenic and tolerogenic. This work presents a means to generate in vitro from monocytes, immature monocyte derived dendritic cells (moDCs), tolerogenic and mature moDCs that differ in surface marker expression, function and metabolic phenotypes.

Citing Articles

Mesenchymal Stem Cell-Immune Cell Interaction and Related Modulations for Bone Tissue Engineering.

Chen R, Hao Z, Wang Y, Zhu H, Hu Y, Chen T Stem Cells Int. 2022; 2022:7153584.

PMID: 35154331 PMC: 8825274. DOI: 10.1155/2022/7153584.


Immunogenicity of personalized dendritic-cell therapy in HIV-1 infected individuals under suppressive antiretroviral treatment: interim analysis from a phase II clinical trial.

de Almeida Baptista M, Teodoro Da Silva L, Samer S, Miyuki Oshiro T, Shytaj I, Giron L AIDS Res Ther. 2022; 19(1):2.

PMID: 35022035 PMC: 8753935. DOI: 10.1186/s12981-021-00426-z.


Endoplasmic reticulum stress-induced release and binding of calreticulin from human ovarian cancer cells.

Abdullah T, Whatmore J, Bremer E, Slibinskas R, Michalak M, Eggleton P Cancer Immunol Immunother. 2021; 71(7):1655-1669.

PMID: 34800147 PMC: 9188521. DOI: 10.1007/s00262-021-03072-6.


Role of Immune Cell Diversity and Heterogeneity in Corneal Graft Survival: A Systematic Review and Meta-Analysis.

Zhu J, Inomata T, Di Zazzo A, Kitazawa K, Okumura Y, Coassin M J Clin Med. 2021; 10(20).

PMID: 34682792 PMC: 8537034. DOI: 10.3390/jcm10204667.


Moving on From Sipuleucel-T: New Dendritic Cell Vaccine Strategies for Prostate Cancer.

Sutherland S, Ju X, Horvath L, Clark G Front Immunol. 2021; 12:641307.

PMID: 33854509 PMC: 8039370. DOI: 10.3389/fimmu.2021.641307.


References
1.
Hemmi H, Akira S . TLR signalling and the function of dendritic cells. Chem Immunol Allergy. 2005; 86:120-135. DOI: 10.1159/000086657. View

2.
Jefford M, Schnurr M, Toy T, Masterman K, Shin A, Beecroft T . Functional comparison of DCs generated in vivo with Flt3 ligand or in vitro from blood monocytes: differential regulation of function by specific classes of physiologic stimuli. Blood. 2003; 102(5):1753-63. DOI: 10.1182/blood-2002-12-3854. View

3.
Pearce E, Everts B . Dendritic cell metabolism. Nat Rev Immunol. 2014; 15(1):18-29. PMC: 4495583. DOI: 10.1038/nri3771. View

4.
Paavonen J, Lehtinen M . Interactions between human papillomavirus and other sexually transmitted agents in the etiology of cervical cancer. Curr Opin Infect Dis. 2006; 12(1):67-71. DOI: 10.1097/00001432-199902000-00012. View

5.
Puc J, Kwiatkowski P, Pacanowski J, Wardawa A, Mazurek A, Rowinski W . Mitochondrial activity after cold preservation of pancreatic islet cells treated with pefloxacin (PFX). Ann Transplant. 1998; 3(1):38-41. View